Chairs Rodgers and Guthrie Announce Legislative Hearing on Drug Shortages

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) today announced a legislative hearing titled "Legislative Proposals to Prevent and Respond to Generic Drug Shortages."

“Cancer patients in need of lifesaving treatments have been rocked by shortages in generic medicines driven, in large part, by economic issues and government policies. Addressing the root causes of these shortages will require a multifaceted approach. We thank everyone for their feedback and collaboration and look forward to moving closer to find long-term solutions to prevent drug shortages for patients,” said Chairs Rodgers and Guthrie. 

Subcommittee on Health hearing titled "Legislative Proposals to Prevent and Respond to Generic Drug Shortages." 

WHAT: A hearing to discuss legislative proposals to prevent and respond to generic drug shortages.  

DATE: Thursday, September 14, 2023 

TIME: 10:00 AM ET 

LOCATION: 2123 Rayburn House Office Building   

WITNESSES: Witnesses will be announced and are by invitation only. 


  • H.R. ___, the Stop Drug Shortages Act (Rep. Rodgers) 
  • H.R. 3008, the Drug Shortage Prevention Act of 2023 (Rep. Jacobs)  
  • H.R. 3810, the Drug Origin Transparency Act of 2023 (Rep. Eshoo)  
  • H.R. 3793, the Ensuring Access to Lifesaving Drugs Act of 2023 (Rep. Slotkin)  
  • H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 (Rep. Griffith) 

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at If you have any questions concerning the hearing, please contact Jolie Brochin with the Committee staff at If you have any press-related questions, please contact Christopher Krepich at


July 28, 2023: Chair Rodgers Unveils Proposal to Address Root Cause of Drug Shortages Facing American Patients 

July 18, 2023: E&C Republicans Press FDA Over Inadequate Inspection of Drug Manufacturing in India and China  

June 12, 2023: Chair Rodgers and Ranking Member Crapo sent an RFI to stakeholders and experts.   

May 11, 2023: Chair Rodgers and OI Subcommittee Chair Morgan Griffith (R-VA) convene subcommittee hearing titled “Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains.”   

March 27, 2023: Chair Rodgers and Subcommittee Chair Griffith, and Subcommittee on Health Chair Brett Guthrie (R-KY) wrote to the FDA requesting information into how the agency is managing drug shortages. 

You can read the FDA’s response here, which notes that only 44 percent of companies are complying with existing requirements to report information on the volume of drugs made at each facility to the FDA.